KPTI
Karyopharm Therapeutics Inc.
NASDAQ · USHealthcareBiotechnology
$7.47-21.45%
Price as of Jul 20, 2026
KPTI valuation
Karyopharm Therapeutics Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 4.75x
- P/S forward
- 1.08x
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -0.64x
- Price / sales
- 1.12x
- Price / cash flow
- -2.86x
Enterprise value
- Enterprise value
- $309.3M
- EV / sales
- 2.05x
- EV / EBITDA
- -2.09x
- EV / EBIT
- -3.67x
- Market cap
- $169.3M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.